Cytokine Storm: Clinical Trials

3 trials for Cytokine Storm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown, 1 withdrawn. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Unknown 1, Withdrawn 1
Phase 23Completed 1, Unknown 1, Withdrawn 1

Follow Cytokine Storm: new trials by email Literature Review of Cytokine Storm trials Research Report on Cytokine Storm

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19
DeltaRex-G - COVID-19, Cytokine Storm
Phase 1 / Phase 2WithdrawnAveni Foundation2022-12-122025-02-24
Menstrual Blood Stem Cells in Severe Covid-19
Allogeneic human menstrual blood stem cells secretome, Intravenous saline injection - Covid19, Cytokine Storm
Phase 1 / Phase 2CompletedAvicenna Research Institute292021-04-172021-09-02
Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients
Collagen-Polyvinylpyrrolidone - Covid19, Cytokine Storm
Phase 1 / Phase 2UnknownJanette Furuzawa Carballeda902020-08-192021-02-17

Narrower conditions

COVID-19 (3)  ·  Cytokine Release Syndrome (3)  ·  Pulmonary Fibrosis (1)  ·  Respiratory Distress Syndrome (1)

Broader conditions

Coronaviridae Infections (3)  ·  Coronavirus Infections (3)  ·  Infections (3)  ·  Inflammation (3)  ·  Lung Diseases (3)  ·  Nidovirales Infections (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Pneumonia (3)  ·  Pneumonia, Viral (3)  ·  RNA Virus Infections (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Shock (3)  ·  Systemic Inflammatory Response Syndrome (3)

Interventions

collagen-PVP (1)  ·  retrovector encoding mutant anti-cyclin G1 (1)

Sponsors

Aveni Foundation (1)  ·  Avicenna Research Institute (1)  ·  Janette Furuzawa Carballeda (1)

Countries

Iran (1)  ·  Mexico (1)

Top investigators

Ali Dehghan-Manshadi, MD (1)  ·  Daniel Azamar-Llamas, MD (1)  ·  Eric Ochoa-Hein, MD (1)  ·  Gonzalo Torres-Villalobos, MD, PhD (1)  ·  Janette Furuzawa-Carballeda, PhD (1)  ·  Luis A Septien-Stute, MD (1)  ·  Mina Fathi Kazerooni, MD, PhD (1)  ·  Samrand Fattah-Ghazi, MD (1)  ·  Sant P Chawla, MD (1)  ·  Somaieh Kazemnejad, PhD (1)

Results publications

PMID 10415784, PMID 12563677, PMID 14719037, PMID 15663512, PMID 17181919, PMID 18097874, PMID 19397687, PMID 19453649, PMID 19998041, PMID 21131395, PMID 22028728, PMID 22545014, PMID 22731679, PMID 26867177, PMID 28584818, PMID 30473697, PMID 31986264, PMID 32035018, PMID 32089354, PMID 32113509, PMID 32125455, PMID 32159775, PMID 32192578, PMID 32203186, PMID 32234467, PMID 32257537, PMID 32278362, PMID 32283152, PMID 32360286, PMID 32396163, PMID 35255966, PMID 9804346